INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research

Scientists at Rejuveron Vascular Therapeutics AG, a company specializing in the development of therapies to tackle neurodegeneration, are using INTEGRA’s VIAFLO 384 handheld electronic pipette to accelerate their research. Combining this convenient benchtop system with endothelial cells cultured in Corning® HTS Transwell® 96 well plates allows the team to investigate the ability of drugs to penetrate the blood brain barrier (BBB).

Image Credit: INTEGRA

Vasco Ledebur de Antas de Campos, Head of Discovery Biology at Rejuveron Vascular Therapeutics, explained: “We deposit cells in the Transwells, and incubate them to form a monolayer on the filter membrane in each well. Once we have obtained high confluency – which simulates the BBB – we administer the drug candidates.”

“We use a VIAFLO 384 – with a 96 channel head and 125 µl Sterile Filter GripTips – to both deliver the drugs to the apical side and take samples from the basolateral side of the Transwells. This allows us to check the amount of each drug that was able to permeate the barrier. This approach would be difficult to perform with a standard multichannel pipette, as we are often screening large libraries. In contrast, it’s a simple task for the VIAFLO 384, since you can easily program the system to aspirate from any part of the well.”

“I love working with the VIAFLO 384. The system is easy to set up and optimize and, in addition, it is very flexible. For example, you do not need to load the whole deck, but can use just a single column or row, which means that we can use the system to set up and study dose responses,”


Visit the INTEGRA Biosciences website to learn more.

About INTEGRA Biosciences

INTEGRA Biosciences is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world.

More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2024, January 29). INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research. AZoLifeSciences. Retrieved on July 21, 2024 from

  • MLA

    INTEGRA Biosciences. "INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research". AZoLifeSciences. 21 July 2024. <>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research". AZoLifeSciences. (accessed July 21, 2024).

  • Harvard

    INTEGRA Biosciences. 2024. INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research. AZoLifeSciences, viewed 21 July 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
INTEGRA solutions helping to support a new generation of RNA sequencing